Invention Grant
- Patent Title: Treatment of protein aggregation diseases
- Patent Title (中): 治疗蛋白质聚集疾病
-
Application No.: US12525381Application Date: 2008-01-30
-
Publication No.: US08383617B2Publication Date: 2013-02-26
- Inventor: Stuart Mark Wilson , Christopher John Stanley
- Applicant: Stuart Mark Wilson , Christopher John Stanley
- Applicant Address: GB London
- Assignee: PAD Pharma Limited
- Current Assignee: PAD Pharma Limited
- Current Assignee Address: GB London
- Agency: Pillsbury Winthrop Shaw Pittman LLP
- Priority: GB0701970.6 20070201; GB0704105.6 20070302
- International Application: PCT/EP2008/051134 WO 20080130
- International Announcement: WO2008/092898 WO 20080807
- Main IPC: A61K31/135
- IPC: A61K31/135 ; A61K31/382 ; A61K31/496 ; A61K31/5415 ; A61K31/55 ; A61K31/554
Abstract:
A method of treatment for the prevention or therapy of a protein aggregation disease includes the administration in combination of a first active medicament and a second active medicament, wherein the first active medicament is active to impede aggregation of amyloid protein and the second active medicament is active to disaggregate previously formed aggregates of amyloid protein.
Public/Granted literature
- US20100035859A1 TREATMENT OF PROTEIN AGGREGATION DISEASES Public/Granted day:2010-02-11
Information query
